Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd

<< Previous

Bullboard Posts

Next >>

Post by cool888on Mar 13, 2021 5:35pm

210 Views

Post# 32793693

BUC - FDA approval and EUA to treat News Monday/this week ?

It's TIME now FDA ! World needs BUCILLAMINE immediatley to SAVE LIVES !!!

GERMANY -

“We have clear signs: The third wave in Germany has already begun,” Lothar Wieler, head of the Robert Koch Institute for Infectious Diseases, told reporters during a news conference Friday.

ITALY -

Italy, meanwhile, is reportedly set to impose another near national lockdown over the Easter weekend in an effort to curb the spread of the virus.

FRANCE -

With the government struggling to contain the spread, France reported 29,759 new COVID-19 cases on Saturday, up from 25,229 the previous day, the data showed.

UK -